For over 20 years we have been leading the way as a contract research organisation for the Biotech and Pharmaceutical sectors. We offer a preclinical drug evaluation service specialising in models of cardiovascular and inflammatory diseases.
We offer disease models covering therapeutic areas such as arthritis, cardiovascular disease, diabetes, inflammatory and renal diseases as well as cell-based assays and more.
Our expert team of Senior Scientists offer one-to-one discussions and advice on your preclinical testing needs so you get your drug tested in the right model first time.
Join us for a selection of scientific meetings and talks concerning recent developments in biomedical research.
The William Harvey Research Foundation is a charity promoting and supporting fundamental research into cardiovascular and inflammatory disease, leading to new understanding of the human body, which advances the discovery of new medicines.
With more than 500 researchers, William Harvey Research Institute is part of Queen Mary University of London (QMUL) and one of the leading centres in the United Kindom for pharmacological research, and is now world-renowned as a centre of excellence for cardiovascular and inflammation research.
We use cookies to improve your experience of our site.
By continuing to browse the site you are agreeing to our use of cookies. ContinueFind out more